Elevance Health Inc.
Profit after direct costs
Core business profitability
Bottom line profitability
Top line growth rate
Flow of revenue through cost categories to net income
| Item | Trend | 2021 | 2022 | 2023 | 2024 | 2025 | YoY Change |
|---|---|---|---|---|---|---|---|
Total Revenue | 138.64B | 156.59B | 171.34B | 176.81B | 199.13B | 12.6% | |
| Cost of Revenue | (102.64B) | (116.64B) | (124.33B) | (127.57B) | (148.22B) | 16.2% | |
Gross Profit | 35.99B | 39.95B | 47.01B | 49.24B | 50.90B | 3.4% | |
| Operating Expenses | |||||||
| Research & Development | — | — | — | — | — | — | |
| Selling, General & Administrative | — | — | — | — | — | — | |
| Depreciation & Amortization | (1.30B) | (1.68B) | (1.75B) | (1.39B) | (1.55B) | 11.0% | |
Operating Income (EBIT) | 8.95B | 8.45B | 8.74B | 8.89B | 8.11B | -8.7% | |
| Non-Operating Items | |||||||
| Interest Income | — | — | — | — | — | — | |
| Interest Expense | (798.00M) | (851.00M) | (1.03B) | (1.19B) | (1.40B) | 18.3% | |
| Other Income/Expenses (Net) | -1.02B | -851.00M | -1.03B | -984.00M | -1.40B | 42.5% | |
Income Before Tax | 7.92B | 7.60B | 7.71B | 7.90B | 6.71B | -15.1% | |
| Income Tax Expense | (1.83B) | (1.71B) | (1.72B) | (1.93B) | (1.05B) | -45.7% | |
Net Income | 6.10B | 5.89B | 5.99B | 5.98B | 5.66B | -5.3% | |
| Per Share Metrics | |||||||
| Earnings Per Share (Basic) | $25 | $25 | $25 | $26 | $25 | -2.4% | |
| Weighted Avg Shares Outstanding | 243.80M | 240.00M | 233.07M | 232.87M | 221.80M | -4.8% | |
| Weighted Avg Shares Outstanding (Diluted) | 246.80M | 242.80M | 237.40M | 232.90M | 221.80M | -4.8% | |
EBITDA | 10.03B | 10.13B | 10.49B | 10.48B | 9.66B | -7.9% |
Explore ELV
ELV in the Healthcare
Large Cap